Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

DOI record: { "DOI": "10.1016/j.eclinm.2020.100645", "ISSN": [ "2589-5370" ], "URL": "http://dx.doi.org/10.1016/j.eclinm.2020.100645", "alternative-id": [ "S2589537020303898" ], "article-number": "100645", "author": [ { "affiliation": [], "family": "Omrani", "given": "Ali S.", "sequence": "first" }, { "affiliation": [], "family": "Pathan", "given": "Sameer A.", "sequence": "additional" }, { "affiliation": [], "family": "Thomas", "given": "Sarah A.", "sequence": "additional" }, { "affiliation": [], "family": "Harris", "given": "Tim R.E.", "sequence": "additional" }, { "affiliation": [], "family": "Coyle", "given": "Peter V.", "sequence": "additional" }, { "affiliation": [], "family": "Thomas", "given": "Caroline E.", "sequence": "additional" }, { "affiliation": [], "family": "Qureshi", "given": "Isma", "sequence": "additional" }, { "affiliation": [], "family": "Bhutta", "given": "Zain A.", "sequence": "additional" }, { "affiliation": [], "family": "Mawlawi", "given": "Naema Al", "sequence": "additional" }, { "affiliation": [], "family": "Kahlout", "given": "Reham Al", "sequence": "additional" }, { "affiliation": [], "family": "Elmalik", "given": "Ashraf", "sequence": "additional" }, { "affiliation": [], "family": "Azad", "given": "Aftab M.", "sequence": "additional" }, { "affiliation": [], "family": "Daghfal", "given": "Joanne", "sequence": "additional" }, { "affiliation": [], "family": "Mustafa", "given": "Mulham", "sequence": "additional" }, { "affiliation": [], "family": "Jeremijenko", "given": "Andrew", "sequence": "additional" }, { "affiliation": [], "family": "Soub", "given": "Hussam Al", "sequence": "additional" }, { "affiliation": [], "family": "Khattab", "given": "Mohammed Abu", "sequence": "additional" }, { "affiliation": [], "family": "Maslamani", "given": "Muna Al", "sequence": "additional" }, { "affiliation": [], "family": "Thomas", "given": "Stephen H.", "sequence": "additional" } ], "container-title": "EClinicalMedicine", "container-title-short": "EClinicalMedicine", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2020, 11, 20 ] ], "date-time": "2020-11-20T22:24:37Z", "timestamp": 1605911077000 }, "deposited": { "date-parts": [ [ 2021, 5, 13 ] ], "date-time": "2021-05-13T12:00:34Z", "timestamp": 1620907234000 }, "funder": [ { "DOI": "10.13039/100007833", "doi-asserted-by": "publisher", "name": "Hamad Medical Corporation" } ], "indexed": { "date-parts": [ [ 2024, 1, 25 ] ], "date-time": "2024-01-25T15:46:37Z", "timestamp": 1706197597142 }, "is-referenced-by-count": 42, "issued": { "date-parts": [ [ 2020, 12 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 12, 1 ] ], "date-time": "2020-12-01T00:00:00Z", "timestamp": 1606780800000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 11, 6 ] ], "date-time": "2020-11-06T00:00:00Z", "timestamp": 1604620800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2589537020303898?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2589537020303898?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100645", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 12 ] ] }, "published-print": { "date-parts": [ [ 2020, 12 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.eclinm.2020.100645_bib0001", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101663", "article-title": "Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study", "author": "Gautret", "doi-asserted-by": "crossref", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0002", "volume": "34", "year": "2020" }, { "author": "Molina", "journal-title": "Med Mal Infect", "key": "10.1016/j.eclinm.2020.100645_bib0003", "year": "2020" }, { "key": "10.1016/j.eclinm.2020.100645_bib0004", "unstructured": "Ferner R.E., Aronson J.K... Hydroxychloroquine for Covid-19: what do the clinical trials tell us? 2020. https://www.cebm.net/covid-19/hydroxychloroquine-for-covid-19-what-do-the-clinical-trials-tell-us/ (accessed 20 April 2020)." }, { "key": "10.1016/j.eclinm.2020.100645_bib0005", "unstructured": "Q-PROTECT Research Protocol. 2020. https://www.hamad.qa/EN/Hospitals-and-services/Communicable-Disease-Center/Research-and-Education/Pages/Q-Protect.aspx (accessed 1 August 2020)." }, { "key": "10.1016/j.eclinm.2020.100645_bib0006", "unstructured": "Simpson T.F., Kovacs R.J., Stecker E.C.. Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for Covid-19. 2020. https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19 (accessed 1 April 2020)." }, { "DOI": "10.1056/NEJMc2001737", "article-title": "SARS-CoV-2 viral load in upper respiratory specimens of infected patients", "author": "Zou", "doi-asserted-by": "crossref", "first-page": "1177", "issue": "12", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2020.100645_bib0007", "volume": "382", "year": "2020" }, { "DOI": "10.1016/j.jclinepi.2020.04.016", "article-title": "COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine", "author": "Alexander", "doi-asserted-by": "crossref", "first-page": "120", "journal-title": "J Clin Epidemiol", "key": "10.1016/j.eclinm.2020.100645_bib0008", "volume": "123", "year": "2020" }, { "DOI": "10.1056/NEJMoa2016638", "article-title": "A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19", "author": "Boulware", "doi-asserted-by": "crossref", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2020.100645_bib0009", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101738", "article-title": "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France", "author": "Million", "doi-asserted-by": "crossref", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0010", "volume": "35", "year": "2020" }, { "article-title": "Hydroxychloroquine for early treatment of adults with mild covid-19: a randomized-controlled trial", "author": "Mitja", "journal-title": "Clin Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0011", "year": "2020" }, { "DOI": "10.7326/M20-4207", "article-title": "Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial", "author": "Skipper", "doi-asserted-by": "crossref", "journal-title": "Ann Intern Med", "key": "10.1016/j.eclinm.2020.100645_bib0012", "year": "2020" }, { "DOI": "10.1136/bmj.m1849", "article-title": "Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial", "author": "Tang", "doi-asserted-by": "crossref", "first-page": "m1849", "journal-title": "BMJ", "key": "10.1016/j.eclinm.2020.100645_bib0013", "volume": "369", "year": "2020" }, { "article-title": "A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19", "author": "Chen", "first-page": "215", "issue": "2", "journal-title": "Zhejiang Da Xue Xue Bao Yi Xue Ban", "key": "10.1016/j.eclinm.2020.100645_bib0014", "volume": "49", "year": "2020" }, { "article-title": "Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19", "author": "Yu", "journal-title": "Sci China Life Sci", "key": "10.1016/j.eclinm.2020.100645_bib0015", "year": "2020" }, { "DOI": "10.1056/NEJMoa2012410", "article-title": "Observational study of hydroxychloroquine in hospitalized patients with covid-19", "author": "Geleris", "doi-asserted-by": "crossref", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2020.100645_bib0016", "year": "2020" }, { "DOI": "10.1001/jama.2020.8630", "article-title": "Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State", "author": "Rosenberg", "doi-asserted-by": "crossref", "journal-title": "JAMA", "key": "10.1016/j.eclinm.2020.100645_bib0017", "year": "2020" }, { "DOI": "10.1136/bmj.m1844", "article-title": "Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data", "author": "Mahevas", "doi-asserted-by": "crossref", "first-page": "m1844", "journal-title": "BMJ", "key": "10.1016/j.eclinm.2020.100645_bib0018", "volume": "369", "year": "2020" }, { "DOI": "10.1001/jamacardio.2020.1782", "article-title": "Hydroxychloroquine, coronavirus disease 2019, and QT prolongation", "author": "Bonow", "doi-asserted-by": "crossref", "journal-title": "JAMA Cardiol", "key": "10.1016/j.eclinm.2020.100645_bib0019", "year": "2020" }, { "article-title": "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis", "author": "Mehra", "journal-title": "Lancet", "key": "10.1016/j.eclinm.2020.100645_bib0020", "year": "2020" }, { "key": "10.1016/j.eclinm.2020.100645_bib0021", "unstructured": "Horby P., Landray M.J... No clinical benefit from use of hydroxychloroquine in hospitalised patients with Covid-19. 2020. https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19 (accessed 1 July 2020)." }, { "key": "10.1016/j.eclinm.2020.100645_bib0022", "unstructured": "FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or (accessed 15 July 2020)." }, { "key": "10.1016/j.eclinm.2020.100645_bib0023", "unstructured": "WHO. \"Solidarity\" clinical trial for Covid-19 treatments. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments (accessed 15 July 2020)." }, { "DOI": "10.1056/NEJMoa2019014", "article-title": "Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19", "author": "Cavalcanti", "doi-asserted-by": "crossref", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2020.100645_bib0024", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.06.099", "article-title": "Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19", "author": "Arshad", "doi-asserted-by": "crossref", "first-page": "396", "journal-title": "Int J Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0025", "volume": "97", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101791", "article-title": "Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: a retrospective analysis", "author": "Lagier", "doi-asserted-by": "crossref", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0026", "year": "2020" }, { "DOI": "10.1056/NEJMe2020388", "article-title": "Hydroxychloroquine for the prevention of Covid-19 – searching for evidence", "author": "Cohen", "doi-asserted-by": "crossref", "first-page": "585", "issue": "6", "journal-title": "N Engl J Med", "key": "10.1016/j.eclinm.2020.100645_bib0027", "volume": "383", "year": "2020" }, { "DOI": "10.1016/j.jinf.2020.06.034", "article-title": "Low transmission risk of 9 asymptomatic carriers tested positive for both SARS-CoV-2 nucleic acid and serum IgG", "author": "Chen", "doi-asserted-by": "crossref", "journal-title": "J Infect", "key": "10.1016/j.eclinm.2020.100645_bib0028", "year": "2020" }, { "article-title": "Temporal dynamics in viral shedding and transmissibility of COVID-19", "author": "He", "journal-title": "Nat Med", "key": "10.1016/j.eclinm.2020.100645_bib0029", "year": "2020" }, { "DOI": "10.1093/ofid/ofaa130", "article-title": "Review: hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)", "author": "Pastick", "doi-asserted-by": "crossref", "first-page": "ofaa130", "issue": "4", "journal-title": "Open Forum Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0030", "volume": "7", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "732", "issue": "15", "journal-title": "Clin Infect Dis", "key": "10.1016/j.eclinm.2020.100645_bib0031", "volume": "71", "year": "2020" }, { "DOI": "10.2174/1573403X10666140514103612", "article-title": "The measurement of the QT interval", "author": "Postema", "doi-asserted-by": "crossref", "first-page": "287", "issue": "3", "journal-title": "Curr Cardiol Rev", "key": "10.1016/j.eclinm.2020.100645_bib0032", "volume": "10", "year": "2014" }, { "DOI": "10.1001/jamacardio.2020.1787", "article-title": "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit", "author": "Bessiere", "doi-asserted-by": "crossref", "journal-title": "JAMA Cardiol", "key": "10.1016/j.eclinm.2020.100645_bib0033", "year": "2020" } ], "reference-count": 33, "references-count": 33, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2589537020303898" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": "Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19", "type": "journal-article", "volume": "29-30" }